[Media Releases] [News MK Economy]Sanofi, joint research with LegoChem Biosciences on cadidate substances.

Title: News MK Economy– Sanofi, joint research with LegoChem Biosciences on cadidate substances.

Publication: MK Economy

Date: 31 July 2012

Summary

• On 31st, Sanofi and LegoChem agreed on joint research of candidate substances for drugs that can treat diseases with high prevalence rate among Asians.

To view the full article (in Korean), click here ▶

About LegoChem Biosciences

LegoChem Biosciences, Inc. (LCB) is a research-based biotechnology company dedicated to discovering, developing, and commercializing innovative medicines by leveraging our chemistry expertise to make conventional biologics targeted and more potent for the benefit of patients with diseases of high unmet medical needs. We are advancing sustainable pipelines in therapeutic areas in antibiotics, anti-coagulants, oncology, antibody-drug conjugate (ADC), and protein-drug conjugate (PDC).